Clinical Trials Browser

Phase 1/2 × Anatomic Stage II Breast Cancer AJCC v8 × 90 days × Clear all

NCT05319873 2026-05-11

Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer

Phase 1/2 Active not recruiting

Anatomic Stage II Breast Cancer AJCC v8